234 related articles for article (PubMed ID: 10741006)
21. A cellular pertussis vaccine (Infanrix-DTPa; SB-3). A review of its immunogenicity, protective efficacy and tolerability in the prevention of Bordetella pertussis infection.
Patel SS; Wagstaff AJ
Drugs; 1996 Aug; 52(2):254-75. PubMed ID: 8841742
[TBL] [Abstract][Full Text] [Related]
22. Half-dose immunization for diphtheria, tetanus, pertussis: response of preterm infants.
Bernbaum J; Daft A; Samuelson J; Polin RA
Pediatrics; 1989 Apr; 83(4):471-6. PubMed ID: 2538797
[TBL] [Abstract][Full Text] [Related]
23. Diphtheria-tetanus-acellular pertussis vaccine adsorbed (Triacelluvax; DTaP3-CB): a review of its use in the prevention of Bordetella pertussis infection.
Matheson AJ; Goa KL
Paediatr Drugs; 2000; 2(2):139-59. PubMed ID: 10937466
[TBL] [Abstract][Full Text] [Related]
24. A phase III, randomized controlled study to assess the safety and immunogenicity of a semi-synthetic diphtheria, tetanus and whole-cell pertussis vaccine in Indian infants.
Sharma H; Patil V; Sharma D; Kapre S; Jadhav S; Ravetkar S; Kumar R; Bahl S; Parekh S; Chakravarty A
Vaccine; 2012 Sep; 30(43):6157-62. PubMed ID: 22874850
[TBL] [Abstract][Full Text] [Related]
25. Antibody response to diphtheria-tetanus-pertussis immunization in preterm infants who receive dexamethasone for chronic lung disease.
Robinson MJ; Heal C; Gardener E; Powell P; Sims DG
Pediatrics; 2004 Apr; 113(4):733-7. PubMed ID: 15060220
[TBL] [Abstract][Full Text] [Related]
26. Reduced-antigen, combined diphtheria, tetanus, and acellular pertussis vaccine (Boostrix): a review of its use as a single-dose booster immunization.
Frampton JE; Keating GM
BioDrugs; 2006; 20(6):371-89. PubMed ID: 17176125
[TBL] [Abstract][Full Text] [Related]
27. Immunogenicity and reactogenicity of a Haemophilus influenzae type b tetanus conjugate vaccine when administered separately or mixed with concomitant diphtheria-tetanus-toxoid and acellular pertussis vaccine for primary and for booster immunizations.
Schmitt HJ; Zepp F; Müschenborn S; Sümenicht G; Schuind A; Beutel K; Knuf M; Bock HL; Bogaerts H; Clemens R
Eur J Pediatr; 1998 Mar; 157(3):208-14. PubMed ID: 9537487
[TBL] [Abstract][Full Text] [Related]
28. Immunogenicity and reactogenicity of two diphtheria-tetanus-whole cell pertussis vaccines in Iranian pre-school children, a randomized controlled trial.
Zarei S; Jeddi-Tehrani M; Mehdi Akhondi M; Zeraati H; Ferydonfar AA; Nasernia J; Tavangar B; Shokri F
Hum Vaccin Immunother; 2013 Jun; 9(6):1316-22. PubMed ID: 23442608
[TBL] [Abstract][Full Text] [Related]
29. Immune response to a diphtheria and tetanus toxoid administration in a three-dose diphtheria tetanus whole-cell pertussis/enhanced inactivated poliovirus vaccination schedule: a 7-year follow up.
Swartz TA; Saliou P; Catznelson E; Blondeau C; Gil I; Peled T; Havkin O; Fletcher M
Eur J Epidemiol; 2003; 18(8):827-33. PubMed ID: 12974560
[TBL] [Abstract][Full Text] [Related]
30. Decennial administration in young adults of a reduced-antigen content diphtheria, tetanus, acellular pertussis vaccine containing two different concentrations of aluminium.
Vandermeulen C; Theeten H; Rathi N; Kuriyakose S; Han HH; Sokal E; Hoppenbrouwers K; Van Damme P
Vaccine; 2015 Jun; 33(26):3026-34. PubMed ID: 25613716
[TBL] [Abstract][Full Text] [Related]
31. Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP).
Broder KR; Cortese MM; Iskander JK; Kretsinger K; Slade BA; Brown KH; Mijalski CM; Tiwari T; Weston EJ; Cohn AC; Srivastava PU; Moran JS; Schwartz B; Murphy TV;
MMWR Recomm Rep; 2006 Mar; 55(RR-3):1-34. PubMed ID: 16557217
[TBL] [Abstract][Full Text] [Related]
32. The effect of reconstitution of an Haemophilus influenzae type b-tentanus toxoid conjugate (PRP-T) vaccine on the immune responses to a diphtheria-tetanus-whole cell pertussis (DTwP) vaccine: a five-year follow-up.
Hoppenbrouwers K; Roelants M; Ethevenaux C; Vandermeulen C; Knops J; Desmyter J
Vaccine; 1999 Jun; 17(20-21):2588-98. PubMed ID: 10418907
[TBL] [Abstract][Full Text] [Related]
33. Immunogenicity and safety of a second booster dose of an acellular pertussis vaccine combined with reduced antigen content diphtheria-tetanus toxoids 10 years after a first booster in adolescence: An open, phase III, non-randomized, multi-center study.
Kovac M; Kostanyan L; Mesaros N; Kuriyakose S; Varman M
Hum Vaccin Immunother; 2018; 14(8):1977-1986. PubMed ID: 29630439
[TBL] [Abstract][Full Text] [Related]
34. Importance of timing of maternal combined tetanus, diphtheria, and acellular pertussis (Tdap) immunization and protection of young infants.
Healy CM; Rench MA; Baker CJ
Clin Infect Dis; 2013 Feb; 56(4):539-44. PubMed ID: 23097585
[TBL] [Abstract][Full Text] [Related]
35. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.
America Academy of Pediatrics Commitee on Infectious Diseases
Pediatrics; 2006 Mar; 117(3):965-78. PubMed ID: 16382131
[TBL] [Abstract][Full Text] [Related]
36. Diphtheria, tetanus and pertussis antibodies in 10-year-old children before and after a booster dose of three toxoids: implications for the timing of a booster dose.
Trollfors B; Knutsson N; Taranger J; Mark A; Bergfors E; Sundh V; Lagergård T
Eur J Pediatr; 2006 Jan; 165(1):14-8. PubMed ID: 16249929
[TBL] [Abstract][Full Text] [Related]
37. Humoral immunity of dTap-IPV vaccine (REPEVAX®) administered one month after dT-IPV vaccine (REVAXIS®) in adults with unknown vaccination history.
Larnaudie S; Guiso N; Baptiste C; Desaint C; Desforges L; Lebon P; Soubeyrand B; Launay O
Hum Vaccin; 2010 Oct; 6(10):829-34. PubMed ID: 20864810
[TBL] [Abstract][Full Text] [Related]
38. Serum antibodies to diphtheria-tetanus-pertussis vaccine components in Argentine children.
Pasetti M; Eriksson P; Ferrero F; Manghi M
Infection; 1997; 25(6):339-45. PubMed ID: 9427051
[TBL] [Abstract][Full Text] [Related]
39. Antibody responses after primary immunization in infants born to women receiving a pertussis-containing vaccine during pregnancy: single arm observational study with a historical comparator.
Ladhani SN; Andrews NJ; Southern J; Jones CE; Amirthalingam G; Waight PA; England A; Matheson M; Bai X; Findlow H; Burbidge P; Thalasselis V; Hallis B; Goldblatt D; Borrow R; Heath PT; Miller E
Clin Infect Dis; 2015 Dec; 61(11):1637-44. PubMed ID: 26374816
[TBL] [Abstract][Full Text] [Related]
40. Seroprevalence of antibodies to diphtheria, tetanus and pertussis among healthy adolescents and adults in Iran.
Pourakbari B; Moradi B; Mirzaee F; Mahmoudi S; Teymuri M; Mamishi S
Roum Arch Microbiol Immunol; 2013; 72(4):250-4. PubMed ID: 24923108
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
